MicroRNA dysregulation and therapeutic opportunities in esophageal diseases
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2023
DOI: 10.1152/ajpgi.00184.2022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2023. Verfasst von Gary E Markey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Allergy, Inflammation & Remodelling Research Laboratory, Department of Biology, Kathleen Lonsdale Institute for Human Health Research, Maynooth Unive…. Hauptthemen laut MEDLINE: MicroRNAs, Gastroesophageal Reflux, Esophageal Neoplasms, Barrett Esophagus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Kathlene Lonsdale Institute for Human Health Research Scholarship, Health Research Board, Science Foundation Ireland.
Abstract (Originalsprache)
MicroRNAs (miRNAs) are a class of small endogenous RNA molecules between 18 and 25 nucleotides long. The primary function of miRNAs is in the posttranscriptional regulation of mRNA targets through RNA interference culminating in mRNA degradation or translational repression. MiRNAs are fundamental in physiological and pathological processes such as cell proliferation, differentiation, apoptosis, and inflammation. Among this includes the uncovered potential of miRNAs in overall esophageal disease with a focus on the clinicopathologic allergic disease eosinophilic esophagitis (EoE), gastroesophageal reflux disease (GERD), and the tumorigenic continuum from Barrett’s esophagus (BE) toward esophageal adenocarcinoma (EAC). Although these pathologies are distinct from one another, they share pathophysiological elements such as an intense inflammatory milieu, esophageal dysfunction, and as presented in this review, an overlap in miRNA expression which contributes to overall esophageal disease. The overlap in the dysregulated miRNA transcriptome of these pathologies highlights the key role miRNAs play in contributing to esophageal disease progression. Owing to this notable dysregulation, there is an attractive utility for miRNAs as diagnostic and prognostic biomarkers in esophageal diseases that already require invasive endoscopies and biopsy retrieval. In this review miRNAs within EoE, GERD, BE, EAC, and esophageal achalasia are discussed, as well as reviewing a core set of miRNAs shared in the disease progression among some of these pathologies, along with the potential utility of targeting miRNAs as therapeutic options in overall esophageal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allergy, Inflammation & Remodelling Research Laboratory, Department of Biology, Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.
- National Esophageal and Gastric Centre, St. James's Hospital Dublin and Trinity St. James's Cancer Institute, Dublin, Ireland.
- Mucosal Immunology Research Laboratory, Department of Biology, Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.
- Gastrointestinal Eosinophilic Diseases Program, Department of Pediatrics, Digestive Health Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, United States.
ORCID-Profile: Joanne C Masterson
Förderung
- Kathlene Lonsdale Institute for Human Health Research Scholarship
- Health Research Board
- Science Foundation Ireland
Zitieren
APA
Markey, G. E., Donohoe, C. L., McNamee, E. N., & Masterson, J. C. (2023). MicroRNA dysregulation and therapeutic opportunities in esophageal diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00184.2022
Vancouver
Markey GE, Donohoe CL, McNamee EN, Masterson JC. MicroRNA dysregulation and therapeutic opportunities in esophageal diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2023. doi:10.1152/ajpgi.00184.2022
BibTeX
@article{Markey2023,
author = {Markey, Gary E and Donohoe, Claire L and McNamee, Eóin N and Masterson, Joanne C},
title = {MicroRNA dysregulation and therapeutic opportunities in esophageal diseases},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2023},
doi = {10.1152/ajpgi.00184.2022}
}
EUVIMED